Listed

CN Healthy Food Tech Group Corp.

UCFINasdaqCIK 1901203Consumer staplesFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$8.7m, Q2 FY2026
Operating income$5.1m, Q2 FY2026
Net income$3.1m, Q2 FY2026
CN Healthy Food Tech Group Corp., income statement, quarterly
Line itemUnitperiod not labelled2023-06-30period not labelled2023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$knot reportednot reportednot reportednot reportednot reported4,292Revenue, Q3 FY2024, three months to 2024-09-30$4.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figurenot reported4,823Revenue, Q1 FY2025, three months to 2025-03-31$4.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure7,460Revenue, Q2 FY2025, three months to 2025-06-30$7.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure7,905Revenue, Q3 FY2025, three months to 2025-09-30$7.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure5,829Revenue, Q1 FY2026, three months to 2026-03-31$5.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure8,734Revenue, Q2 FY2026, three months to 2026-06-30$8.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure
Cost of revenue$knot reportednot reportednot reportednot reportednot reported1,344Cost of revenue, Q3 FY2024, three months to 2024-09-30$1.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figurenot reported2,466Cost of revenue, Q1 FY2025, three months to 2025-03-31$2.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure2,517Cost of revenue, Q2 FY2025, three months to 2025-06-30$2.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure2,338Cost of revenue, Q3 FY2025, three months to 2025-09-30$2.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure1,464Cost of revenue, Q1 FY2026, three months to 2026-03-31$1.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure2,493Cost of revenue, Q2 FY2026, three months to 2026-06-30$2.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure
Gross profit$knot reportednot reportednot reportednot reportednot reported2,948Gross profit, Q3 FY2024, three months to 2024-09-30$2.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figurenot reported2,357Gross profit, Q1 FY2025, three months to 2025-03-31$2.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure4,943Gross profit, Q2 FY2025, three months to 2025-06-30$4.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure5,568Gross profit, Q3 FY2025, three months to 2025-09-30$5.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure4,365Gross profit, Q1 FY2026, three months to 2026-03-31$4.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure6,241Gross profit, Q2 FY2026, three months to 2026-06-30$6.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure
Research and development$knot reportednot reportednot reportednot reportednot reportednot reportednot reported27.5Research and development, Q1 FY2025, three months to 2025-03-31$27.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure30.9Research and development, Q2 FY2025, three months to 2025-06-30$30.9k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure37.8Research and development, Q3 FY2025, three months to 2025-09-30$37.8k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure38.4Research and development, Q1 FY2026, three months to 2026-03-31$38.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure35.6Research and development, Q2 FY2026, three months to 2026-06-30$35.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure
Operating income$k(60.3)Operating income, period not labelled, three months to 2023-06-30−$60.3k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-08-14, accession 0001213900-24-068618.Report this figure(137)Operating income, period not labelled, three months to 2023-09-30−$137.1k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001213900-24-096270.Report this figure(7.0)Operating income, Q4 FY2023, three months to 2023-12-31−$7.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-21, accession 0001213900-25-015846. Derived: 12-month figure less the 9-month figure.Report this figure(480)Operating income, Q1 FY2024, three months to 2024-03-31−$479.9k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001213900-25-043698.Report this figure(238)Operating income, Q2 FY2024, three months to 2024-06-30−$238.4k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001213900-25-076067.Report this figure2,297Operating income, Q3 FY2024, three months to 2024-09-30$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure(4,382)Operating income, Q4 FY2024, three months to 2024-12-31−$4.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-21, accession 0001213900-25-015846. Derived: 12-month figure less the 9-month figure.Report this figure805Operating income, Q1 FY2025, three months to 2025-03-31$805.2k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure3,874Operating income, Q2 FY2025, three months to 2025-06-30$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure4,584Operating income, Q3 FY2025, three months to 2025-09-30$4.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure731Operating income, Q1 FY2026, three months to 2026-03-31$730.6k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure5,115Operating income, Q2 FY2026, three months to 2026-06-30$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure
Interest expense$knot reportednot reportednot reportednot reportednot reported(9.1)Interest expense, Q3 FY2024, three months to 2024-09-30−$9.1k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figurenot reportednot reported5.6Interest expense, Q2 FY2025, three months to 2025-06-30$5.6k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure(10.1)Interest expense, Q3 FY2025, three months to 2025-09-30−$10.1k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure206Interest expense, Q1 FY2026, three months to 2026-03-31$206.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure130Interest expense, Q2 FY2026, three months to 2026-06-30$129.9k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure
Income tax$knot reportednot reportednot reported211Income tax, Q1 FY2024, three months to 2024-03-31$211.1k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0001213900-25-043698.Report this figure178Income tax, Q2 FY2024, three months to 2024-06-30$178.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-14, accession 0001213900-25-076067.Report this figure744Income tax, Q3 FY2024, three months to 2024-09-30$743.6k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure(20.3)Income tax, Q4 FY2024, three months to 2024-12-31−$20.3k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-02-21, accession 0001213900-25-015846. Derived: 12-month figure less the 9-month figure.Report this figure125Income tax, Q1 FY2025, three months to 2025-03-31$125.1k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure1,106Income tax, Q2 FY2025, three months to 2025-06-30$1.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure1,378Income tax, Q3 FY2025, three months to 2025-09-30$1.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure851Income tax, Q1 FY2026, three months to 2026-03-31$850.5k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure1,506Income tax, Q2 FY2026, three months to 2026-06-30$1.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure
Net income$k(60.3)Net income, period not labelled, three months to 2023-06-30−$60.3k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001213900-24-096270.Report this figure(137)Net income, period not labelled, three months to 2023-09-30−$137.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001213900-24-096270.Report this figure(6.8)Net income, Q4 FY2023, three months to 2023-12-31−$6.8k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-21, accession 0001213900-25-015846. Derived: 12-month figure less the 9-month figure.Report this figure0.4Net income, Q1 FY2024, three months to 2024-03-31$375. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure357Net income, Q2 FY2024, three months to 2024-06-30$356.8k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure1,567Net income, Q3 FY2024, three months to 2024-09-30$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure(548)Net income, Q4 FY2024, three months to 2024-12-31−$548.4k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-21, accession 0001213900-25-015846. Derived: 12-month figure less the 9-month figure.Report this figure774Net income, Q1 FY2025, three months to 2025-03-31$773.7k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure2,922Net income, Q2 FY2025, three months to 2025-06-30$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure3,345Net income, Q3 FY2025, three months to 2025-09-30$3.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure(309)Net income, Q1 FY2026, three months to 2026-03-31−$309.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure3,060Net income, Q2 FY2026, three months to 2026-06-30$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure
Diluted EPS$ per sharenot reportednot reportednot reportednot reportednot reported0.04Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figurenot reported0.02Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure0.06Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure0.07Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure(0.01)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure0.06Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure
Basic EPS$ per sharenot reportednot reportednot reportednot reportednot reported0.04Basic EPS, Q3 FY2024, three months to 2024-09-30$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figurenot reported0.02Basic EPS, Q1 FY2025, three months to 2025-03-31$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure0.06Basic EPS, Q2 FY2025, three months to 2025-06-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure0.07Basic EPS, Q3 FY2025, three months to 2025-09-30$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure(0.01)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure0.06Basic EPS, Q2 FY2026, three months to 2026-06-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure

Balance sheet

Cash and equivalents$23.3m, Q2 FY2026
Shareholders' equity$23.3m, Q2 FY2026
CN Healthy Food Tech Group Corp., balance sheet, quarterly
Line itemUnitperiod not labelled2023-09-30FY20232023-12-27Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30period not labelled2025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reported2.5Cash and equivalents, FY2023, at 2023-12-27$2.5m. XBRL concept us-gaap:Cash. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure0.2Cash and equivalents, Q1 FY2024, at 2024-03-31$179.3k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001213900-24-042972.Report this figure0.1Cash and equivalents, Q2 FY2024, at 2024-06-30$91.4k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001213900-24-068618.Report this figure0.0Cash and equivalents, Q3 FY2024, at 2024-09-30$3.1k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001213900-24-096270.Report this figure41.4Cash and equivalents, FY2024, at 2024-12-31$41.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure0.0Cash and equivalents, Q1 FY2025, at 2025-03-31$88. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001213900-25-043698.Report this figure0.0Cash and equivalents, Q2 FY2025, at 2025-06-30$25.2k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001213900-25-076067.Report this figure37.2Cash and equivalents, Q3 FY2025, at 2025-09-30$37.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure33.0Cash and equivalents, period not labelled, at 2025-12-31$33.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure29.7Cash and equivalents, Q1 FY2026, at 2026-03-31$29.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure23.3Cash and equivalents, Q2 FY2026, at 2026-06-30$23.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure
Current assets$mnot reported0.7Current assets, FY2023, at 2023-12-31$690.1k. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-21, accession 0001213900-25-015846.Report this figure0.5Current assets, Q1 FY2024, at 2024-03-31$544.2k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001213900-24-042972.Report this figure0.2Current assets, Q2 FY2024, at 2024-06-30$239.5k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001213900-24-068618.Report this figure0.1Current assets, Q3 FY2024, at 2024-09-30$71.3k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001213900-24-096270.Report this figure44.0Current assets, FY2024, at 2024-12-31$44.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure0.1Current assets, Q1 FY2025, at 2025-03-31$79.7k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001213900-25-043698.Report this figure0.2Current assets, Q2 FY2025, at 2025-06-30$155.0k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001213900-25-076067.Report this figure46.2Current assets, Q3 FY2025, at 2025-09-30$46.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure36.9Current assets, period not labelled, at 2025-12-31$36.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure31.4Current assets, Q1 FY2026, at 2026-03-31$31.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure27.5Current assets, Q2 FY2026, at 2026-06-30$27.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure
Total assets$mnot reported69.7Total assets, FY2023, at 2023-12-31$69.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-21, accession 0001213900-25-015846.Report this figure70.4Total assets, Q1 FY2024, at 2024-03-31$70.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001213900-24-042972.Report this figure71.0Total assets, Q2 FY2024, at 2024-06-30$71.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001213900-24-068618.Report this figure71.8Total assets, Q3 FY2024, at 2024-09-30$71.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001213900-24-096270.Report this figure50.8Total assets, FY2024, at 2024-12-31$50.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure73.6Total assets, Q1 FY2025, at 2025-03-31$73.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001213900-25-043698.Report this figure73.3Total assets, Q2 FY2025, at 2025-06-30$73.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001213900-25-076067.Report this figure56.2Total assets, Q3 FY2025, at 2025-09-30$56.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure44.7Total assets, period not labelled, at 2025-12-31$44.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure39.1Total assets, Q1 FY2026, at 2026-03-31$39.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure35.2Total assets, Q2 FY2026, at 2026-06-30$35.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure
Current liabilities$mnot reported0.9Current liabilities, FY2023, at 2023-12-31$861.6k. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-21, accession 0001213900-25-015846.Report this figure1.1Current liabilities, Q1 FY2024, at 2024-03-31$1.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001213900-24-042972.Report this figure1.2Current liabilities, Q2 FY2024, at 2024-06-30$1.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001213900-24-068618.Report this figure1.5Current liabilities, Q3 FY2024, at 2024-09-30$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001213900-24-096270.Report this figure39.9Current liabilities, FY2024, at 2024-12-31$39.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure3.4Current liabilities, Q1 FY2025, at 2025-03-31$3.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001213900-25-043698.Report this figure72.4Current liabilities, Q2 FY2025, at 2025-06-30$72.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001213900-25-076067.Report this figure38.2Current liabilities, Q3 FY2025, at 2025-09-30$38.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure24.6Current liabilities, period not labelled, at 2025-12-31$24.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure19.0Current liabilities, Q1 FY2026, at 2026-03-31$19.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure11.7Current liabilities, Q2 FY2026, at 2026-06-30$11.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure
Total liabilities$mnot reported3.4Total liabilities, FY2023, at 2023-12-31$3.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-21, accession 0001213900-25-015846.Report this figure3.6Total liabilities, Q1 FY2024, at 2024-03-31$3.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001213900-24-042972.Report this figure3.7Total liabilities, Q2 FY2024, at 2024-06-30$3.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001213900-24-068618.Report this figure4.0Total liabilities, Q3 FY2024, at 2024-09-30$4.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001213900-24-096270.Report this figure39.9Total liabilities, FY2024, at 2024-12-31$39.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure5.9Total liabilities, Q1 FY2025, at 2025-03-31$5.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001213900-25-043698.Report this figure75.0Total liabilities, Q2 FY2025, at 2025-06-30$75.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001213900-25-076067.Report this figure38.5Total liabilities, Q3 FY2025, at 2025-09-30$38.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure24.9Total liabilities, period not labelled, at 2025-12-31$24.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure19.2Total liabilities, Q1 FY2026, at 2026-03-31$19.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure11.9Total liabilities, Q2 FY2026, at 2026-06-30$11.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure
Shareholders' equity$m(0.5)Shareholders' equity, period not labelled, at 2023-09-30−$477.4k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001213900-24-096270.Report this figure0.0Shareholders' equity, FY2023, at 2023-12-31$1. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure6.9Shareholders' equity, Q1 FY2024, at 2024-03-31$6.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure7.3Shareholders' equity, Q2 FY2024, at 2024-06-30$7.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure9.1Shareholders' equity, Q3 FY2024, at 2024-09-30$9.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure10.8Shareholders' equity, FY2024, at 2024-12-31$10.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure11.6Shareholders' equity, Q1 FY2025, at 2025-03-31$11.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure14.7Shareholders' equity, Q2 FY2025, at 2025-06-30$14.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure17.7Shareholders' equity, Q3 FY2025, at 2025-09-30$17.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure19.9Shareholders' equity, period not labelled, at 2025-12-31$19.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure19.9Shareholders' equity, Q1 FY2026, at 2026-03-31$19.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure23.3Shareholders' equity, Q2 FY2026, at 2026-06-30$23.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure

Cash flow

Operating cash flow−$7.0m, Q2 FY2026
Capital expenditure$14, Q2 FY2026
CN Healthy Food Tech Group Corp., cash flow, quarterly
Line itemUnitQ1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(0.4)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$374.1k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001213900-25-043698.Report this figure(0.1)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$52.9k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001213900-25-076067. Derived: 6-month figure less the 3-month figure.Report this figure22.3Operating cash flow, Q3 FY2024, three months to 2024-09-30$22.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-19, accession 0001213900-25-112657. Derived: 9-month figure less the 6-month figure.Report this figure(22.9)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$22.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-21, accession 0001213900-25-015846. Derived: 12-month figure less the 9-month figure.Report this figure(0.2)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$165.4k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure(1.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001213900-26-089578. Derived: 6-month figure less the 3-month figure.Report this figure(4.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$4.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-19, accession 0001213900-25-112657. Derived: 9-month figure less the 6-month figure.Report this figure(3.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$3.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure(7.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$7.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001213900-26-089578. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reportednot reportednot reported0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$73.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure0.2Capital expenditure, Q2 FY2025, three months to 2025-06-30$194.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001213900-26-089578. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$176.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-19, accession 0001213900-25-112657. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$1.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$14. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001213900-26-089578. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)52.23m, Q2 FY2026
CN Healthy Food Tech Group Corp., shares, quarterly
Line itemUnitQ3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares47.7Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3047,689,349 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure47.7Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3147,689,349 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure47.7Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3047,689,349 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure47.7Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3047,689,349 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-19, accession 0001213900-25-112657.Report this figure52.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3152,234,983 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001213900-26-055809.Report this figure52.2Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3052,234,983 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure

Shares outstanding: 52.23mShares outstanding, period not labelled, at 2026-08-1452,234,983 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-14, accession 0001213900-26-089578.Report this figure at Aug 14, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.